WallStreetZenWallStreetZen

NYSE: CHE
Chemed Corp Stock

Overview
ForecastEarningsRevenueDividendOwnership
$581.69+0.32 (+0.06%)
Updated Apr 17, 2025
CHE Price
$581.69
Fair Value Price
N/A
Market Cap
$8.51B
52 Week Low
$512.12
52 Week High
$623.61
P/E
28.94x
P/B
7.61x
P/S
3.27x
PEG
2.39x
Dividend Yield
0.26%
Revenue
$2.43B
Earnings
$302.00M
Gross Margin
35.1%
Operating Margin
16.5%
Profit Margin
12.4%
Debt to Equity
0.49
Operating Cash Flow
$417M
Beta
0.47
Next Earnings
Apr 22, 2025
Ex-Dividend
N/A
Next Dividend
N/A

CHE Overview

Chemed Corporation participates in two distinct lines of business. Its VITAS Healthcare segment provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the U.S. Its Roto-Rooter segment offers plumbing, drain cleaning, excavation, water restoration, and related services to residential and commercial customers. The company was incorporated in 1970 and is headquartered in Cincinnati, OH.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CHE's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

C
Value
C
Growth
C
Momentum
C
Sentiment
C
Safety
A
Financials
B
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Care Facility

Industry Rating
B
CHE
Ranked#8 of 42

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Pediatrix Medical Group (MD)
$12.82A
Ardent Health Partners (ARDT)
$12.51A
Universal Health Services (UHS)
$174.80A
View Top Medical Care Facility Stocks

Be the first to know about important CHE news, forecast changes, insider trades & much more!

CHE News

Overview

Due Diligence Score

–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CHE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CHE ($581.69) is trading above its intrinsic value of $193.40, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CHE is poor value based on its earnings relative to its share price (28.94x), compared to the US market average (27.98x)
P/E vs Market Valuation
CHE is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CHE due diligence checks available for Premium users.

Valuation

CHE price to earnings (PE)

For valuing profitable companies with steady earnings

Company
28.94x
Industry
14.77x
Market
27.98x
CHE is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CHE is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

CHE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
7.61x
Industry
4.22x
CHE is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CHE price to earnings growth (PEG)

For valuing profitable companies with growth potential

CHE is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

CHE's financial health

Profit margin

Revenue
$640.0M
Net Income
$90.3M
Profit Margin
14.1%
CHE's Earnings (EBIT) of $401.25M... subscribe to Premium to read more.
Interest Coverage Financials
CHE's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.7B
Liabilities
$549.6M
Debt to equity
0.49
CHE's short-term assets ($394.75M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CHE's short-term assets ($394.75M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CHE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CHE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$164.9M
Investing
-$12.5M
Financing
-$212.5M
CHE's operating cash flow ($417.50M)... subscribe to Premium to read more.
Debt Coverage Financials

CHE vs Medical Care Facility Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CHEB$8.51B+0.06%28.94x7.61x
ENSGC$7.35B-0.16%24.33x4.00x
EHCB$10.41B+0.34%22.81x5.04x
DVAC$11.20B-1.04%12.71x92.49x
UHSA$11.36B+0.66%10.19x1.70x
View Top Medical Care Facility Stocks

Chemed Stock FAQ

What is Chemed's quote symbol?

(NYSE: CHE) Chemed trades on the NYSE under the ticker symbol CHE. Chemed stock quotes can also be displayed as NYSE: CHE.

If you're new to stock investing, here's how to buy Chemed stock.

What is the 52 week high and low for Chemed (NYSE: CHE)?

(NYSE: CHE) Chemed's 52-week high was $623.61, and its 52-week low was $512.12. It is currently -6.72% from its 52-week high and 13.58% from its 52-week low.

How much is Chemed stock worth today?

(NYSE: CHE) Chemed currently has 14,636,695 outstanding shares. With Chemed stock trading at $581.69 per share, the total value of Chemed stock (market capitalization) is $8.51B.

Chemed stock was originally listed at a price of $20.72 in Dec 31, 1997. If you had invested in Chemed stock at $20.72, your return over the last 27 years would have been 2,707.38%, for an annualized return of 13.15% (not including any dividends or dividend reinvestments).

How much is Chemed's stock price per share?

(NYSE: CHE) Chemed stock price per share is $581.69 today (as of Apr 17, 2025).

What is Chemed's Market Cap?

(NYSE: CHE) Chemed's market cap is $8.51B, as of Apr 21, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Chemed's market cap is calculated by multiplying CHE's current stock price of $581.69 by CHE's total outstanding shares of 14,636,695.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.